Vanda Pharmaceuticals Inc. Share Price
NASDAQ: VNDAHealthcare
Live Vanda Pharmaceuticals Inc. Share Price Chart
O H L
Vanda Pharmaceuticals Inc. Performance Overview
Days Range
▼
$5.04Low
$5.10High
Markets Today
| Previous Close | $5.11 |
|---|---|
| Open | $5.07 |
| Volume | 124,330 |
| Day's Range | $5.04 - $5.10 |
| 52W Range | $4.27 - $9.94 |
| Market Cap | $302.31 M |
Historical Performance
| 1M Returns | -6.07 |
|---|---|
| 3M Returns | -11.90 |
| 6M Returns | -40.30 |
| 1Y Returns | +13.05 |
| 5Y Returns | -69.85 |
| 10Y Returns | -66.38 |
Vanda Pharmaceuticals Inc. Fundamentals
| Market Cap | $302.31 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $216.10 M |
| ROE TTM | -0.51 |
| EPS TTM | $-4.63 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.37 |
| EBITDA | $-143.06 M |
| Profit Margin | -102.02 |
| Market Cap | $302.31 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $216.10 M |
| ROE TTM | -0.51 |
| EPS TTM | $-4.63 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.37 |
| EBITDA | $-143.06 M |
| Profit Margin | -102.02 |
Vanda Pharmaceuticals Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $50.04 M | $52.59 M | $56.26 M | $57.22 M | $51.72 M | $50.53 M |
| Gross Profit + | $46.52 M | $49.85 M | $53.30 M | $53.38 M | $48.56 M | $46.97 M |
| Operating Income | -$41.03 M | -$38.50 M | -$31.28 M | -$40.35 M | -$50.22 M | -$63.81 M |
| EBITDA | -$39.05 M | -$36.48 M | -$29.23 M | -$38.30 M | -$47.96 M | -$61.55 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $1.98 M | $2.02 M | $2.05 M | $2.06 M | $2.26 M | $2.25 M |
| Income Before Tax | -$37.37 M | -$34.89 M | -$28.39 M | -$38.00 M | -$48.42 M | -$62.38 M |
| Income Tax Expense | -$7.87 M | -$7.68 M | -$5.80 M | $103.19 M | $143.00 K | $129.00 K |
| Net Income + | -$29.49 M | -$27.21 M | -$22.59 M | -$141.19 M | -$48.57 M | -$62.51 M |
| Net Profit Margin | -58.94% | -51.73% | -40.15% | -246.76% | -93.91% | -123.72% |
Vanda Pharmaceuticals Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $59.00 K | $59.00 K | $59.00 K | $59.00 K | $60.00 K | $60.00 K |
| Reserve & Surplus | -$203.40 M | -$230.60 M | -$253.04 M | -$394.14 M | -$443.12 M | -$505.81 M |
| Non-Current Liabilities | $16.60 M | $16.93 M | $17.27 M | $16.60 M | $17.18 M | $28.26 M |
| Current Liabilities | $103.92 M | $121.49 M | $117.87 M | $145.16 M | $135.58 M | $164.03 M |
| Total Liabilities | $120.52 M | $138.42 M | $135.14 M | $161.76 M | $152.76 M | $192.28 M |
| Fixed Assets | $114.78 M | $113.01 M | $111.30 M | $119.34 M | $117.35 M | $115.69 M |
| Current Assets | $407.91 M | $394.92 M | $367.50 M | $347.26 M | $293.17 M | $264.48 M |
| Total Assets | $631.94 M | $624.75 M | $601.14 M | $488.95 M | $433.52 M | $412.47 M |
Vanda Pharmaceuticals Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$29.49 M | -$27.21 M | -$22.59 M | -$141.19 M | -$48.57 M | -$62.51 M |
| Operating Cash Flow | -$33.15 M | -$15.25 M | -$31.63 M | -$29.42 M | -$50.22 M | -$31.07 M |
| Investing Cash Flow | $43.90 M | -$15.27 M | $21.36 M | $44.87 M | $20.23 M | $33.81 M |
| Financing Cash Flow | -$1.32 M | -$425.00 K | -$517.00 K | -$640.00 K | -$776.00 K | -$856.00 K |
| Change in Cash | $9.48 M | -$30.81 M | -$10.96 M | $14.83 M | -$30.82 M | $1.85 M |
Vanda Pharmaceuticals Inc. Return Calculator
The Vanda Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,997
Invested Amount$10,000
Est. Returns$-7,003
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Popular Stocks
FAQs
What is the share price of Vanda Pharmaceuticals Inc. today?
Vanda Pharmaceuticals Inc. (VNDA) share price as of September 18, 2026 is $5.08. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Vanda Pharmaceuticals Inc.?
Yes, Indian Investors can invest in the Vanda Pharmaceuticals Inc. (VNDA) Share by opening an international trading account with Angel One.
How can I purchase Vanda Pharmaceuticals Inc. shares in India?
Purchasing Vanda Pharmaceuticals Inc. (VNDA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vanda Pharmaceuticals Inc. (VNDA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Vanda Pharmaceuticals Inc.?
Yes, you can purchase fractional shares of Vanda Pharmaceuticals Inc. (VNDA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Vanda Pharmaceuticals Inc.?
The market capitalization of Vanda Pharmaceuticals Inc. on September 18, 2026, is $302.31 M.
In which sector Vanda Pharmaceuticals Inc. belongs?
Vanda Pharmaceuticals Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Vanda Pharmaceuticals Inc. stocks?
In order to invest in Vanda Pharmaceuticals Inc. (VNDA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
